Host: Rabbit
Target Protein: Mannose Receptor(CD206)
Immunogen Range: 1400-1456/1456
Clonality: Monoclonal
Isotype: IgG
Entrez Gene: 4360
Swiss Prot: P22897
Source: Full length protein
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Cross Reactive Species: Human
For research use only. Not intended for diagnostic or therapeutic use.
- Xianmou Fan. et al. A Multifunctional, Tough, Stretchable, and Transparent Curcumin Hydrogel with Potent Antimicrobial, Antioxidative, Anti-inflammatory, and Angiogenesis Capabilities for Diabetic Wound Healing. ACS APPL MATER INTER. 2024;16(8):9749C9767Read more>>
- ingxin Zhao. et al. Thymoquinone regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway. NEUROTOXICOLOGY. 2024 Mar;101:54Read more>>
Lane 1: Human lung lysates; Lane 2: HepG2 lysates; Line 3: 293T lysates; Probed with Mannose Receptor(CD206) (1C4) Monoclonal Antibody (bsm-52791R) at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with Mannose Receptor(CD206) (1C4) Monoclonal Antibody (bsm-52791R) at 1:300 in HeLa cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with Mannose Receptor(CD206) (1C4) Monoclonal Antibody (bsm-52791R) at 1:300 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Lane 1: Human HepG2 cell lysates; Lane 2: Human Hela cell lysates; Lane 3: Human 293T cell lysates; Lane 4: Human MCF-7 cell lysates ; Lane 5: Human Molt-4 cell lysates probed with Mannose Receptor(CD206) (1C4) Monoclonal Antibody, Unconjugated (bsm-52791R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.